Biomarker Jeopardy

Mostrar otras versiones (1)

In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtin, Sandra E., Henglefelt, Alyssa, Mistry, Haleigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126352/
https://www.ncbi.nlm.nih.gov/pubmed/35663183
http://dx.doi.org/10.6004/jadpro.2022.13.3.22
Descripción
Sumario:In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and discussed guidelines for biomarker testing.

Ejemplares similares